News | October 09, 2013

Cianna Medical Receives Approval in Japan for SAVI Breast Brachytherapy

SAVI is the first commercially available intracavitary APBI catheter in Japan

October 9, 2013 — Cianna Medical Inc. announced approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its strut adjusted volume implant (SAVI) applicator in Japan. SAVI delivers accelerated partial breast irradiation (APBI), a five-day course of targeted radiation for early-stage breast cancer patients. The company has partnered with MC Medical Inc., a subsidiary of Mitsubishi Corporation, to bring SAVI to the Japanese healthcare market.

"Entry into Japan is core to our initiative to make SAVI available wherever there is an emergent call to action regarding the treatment of early-stage breast cancer," said Jill Anderson, president and CEO, Cianna Medical. "SAVI uniquely allows women with early-stage breast cancer to be treated in a shorter time frame with less complications, empowering them to reclaim control of their lives more quickly. MC Medical is the ideal partner to convey SAVI's benefits to the Japanese medical community."

According to research, breast cancer rates in Japan will rise by an estimated 24 percent by 2019 to reach 57,000 women compared to 46,000 cases in 2010.  SAVI's strut-based design allows physicians to deliver customized radiation based on patient-specific anatomy. In Japan, where women have relatively smaller breasts, SAVI could make APBI available to a broader swath of patients.

SAVI has been in clinical use in the United States since 2006. The applicator received its CE marking in 2009 and has been in clinical use in Turkey and Poland since 2011. More than 14,000 women have been treated with SAVI.

For more information: www.cinannamedical.com

Related Content

QTbreasthealth Opens Breast Imaging Center in San Jose
News | Ultrasound Women's Health | March 20, 2019
QTbreasthealth has opened a new center in San Jose, Calif. The new location is now open and booking appointments for...
Older Biologic Age Linked to Elevated Breast Cancer Risk
News | Women's Health | March 19, 2019
Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...
Hologic Receives CE Mark for Three-in-One Omni Hysteroscope
News | Endoscopes | March 14, 2019
Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with...
CT, Mammograms Offer Clues to Preventing Heart Problems After Cancer Treatment
News | Cardio-oncology | March 13, 2019
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's...
Sponsored Content | Videos | Artificial Intelligence | March 13, 2019
At RSNA 2018, iCad showed how its...
Hologic Earns CE Mark for LOCalizer Wireless Breast Lesion Localization System
News | Breast Imaging | March 07, 2019
Hologic Inc. announced the granting of a CE Mark to the LOCalizer wireless radio frequency identification (RFID) breast...
South Dakota's Density Inform Bill Signed Into Law
News | Breast Density | March 06, 2019
With the passage of HB1124, South Dakota becomes the 37th state with breast density inform legislation. The law, which...
iCAD Partnering With Karolinska Instituet Researchers on AI-based Breast Cancer Risk Prediction
News | Oncology Diagnostics | March 04, 2019
iCAD announced their intent to enter an exclusive relationship with two leading researchers at The Karolinska...